Hyohun Park

762 total citations
11 papers, 580 citations indexed

About

Hyohun Park is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Hyohun Park has authored 11 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Hyohun Park's work include Liver Disease Diagnosis and Treatment (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Lipid metabolism and disorders (2 papers). Hyohun Park is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Lipid metabolism and disorders (2 papers). Hyohun Park collaborates with scholars based in Japan. Hyohun Park's co-authors include Toshihide Shima, Kohichiroh Yasui, Naoto Nakamura, Hiroshi Obayashi, Michiaki Fukui, Toshikazu Yoshikawa, Goji Hasegawa, Mitsuhiro Ohta, Takeshi Okanoue and Kanji Yamaguchi and has published in prestigious journals such as PLoS ONE, Diabetes Care and Clinica Chimica Acta.

In The Last Decade

Hyohun Park

11 papers receiving 557 citations

Peers

Countries citing papers authored by Hyohun Park

Since Specialization

Citations

This map shows the geographic impact of Hyohun Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyohun Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyohun Park more than expected).

Fields of papers citing papers by Hyohun Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyohun Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyohun Park. The network helps show where Hyohun Park may publish in the future.

Co-authorship network of co-authors of Hyohun Park

This figure shows the co-authorship network connecting the top 25 collaborators of Hyohun Park. A scholar is included among the top collaborators of Hyohun Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyohun Park. Hyohun Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2) 2021 ·Advances in Therapy ·(unknown), Tomoyuki Katsuno, Toshihiko Shiraiwa, (unknown), Hyohun Park, Nobuaki Watanabe, Shizuka Kaneko, Jungo Terasaki, Toshiaki Hanafusa, Akihisa Imagawa, Iichiro Shimomura, Hiroshi Ikegami, Hidenori Koyama, Mitsuyoshi Namba, Jun‐ichiro Miyagawa	3
2	Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese 2012 ·PLoS ONE ·Takahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura, Keitaro Matsuo, Meiko Takahashi, Toshinari Takamura, Kohichiroh Yasui, Toshiji Saibara, Etsuko Hashimoto, Miwa Kawanaka, Sumio Watanabe, Sumio Kawata, Yasuharu Imai, (unknown), Toshihide Shima, Hyohun Park, Hideo Tanaka, Kazuo Tajima, Ryo Yamada, Fumihiko Matsuda, (unknown)	204
3	Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus 2012 ·Journal of Gastroenterology ·Toshihide Shima, Hirofumi Uto, Kohjiro Ueki, Toshinari Takamura, Yutaka Kohgo, Sumio Kawata, Kohichiroh Yasui, Hyohun Park, Naoto Nakamura, Tatsuaki Nakatou, Nobuyoshi Tanaka, Atsushi Umemura, Masayuki Mizuno, Junko Tanaka, Takeshi Okanoue	22
4	Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease 2010 ·Journal of Gastroenterology ·Hyohun Park, Toshihide Shima, Kanji Yamaguchi, Hironori Mitsuyoshi, Masahito Minami, Kohichiroh Yasui, Yoshito Itoh, Toshikazu Yoshikawa, Michiaki Fukui, Goji Hasegawa, Naoto Nakamura, Mitsuhiro Ohta, Hiroshi Obayashi, Takeshi Okanoue	153
5	The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels 2010 ·Clinica Chimica Acta ·Hyohun Park, Goji Hasegawa, Toshihide Shima, Michiaki Fukui, Naoto Nakamura, Kanji Yamaguchi, Hironori Mitsuyoshi, Masahito Minami, Kohichiroh Yasui, Yoshito Itoh, Toshikazu Yoshikawa, Jo Kitawaki, (unknown), Hiroshi Obayashi, Takeshi Okanoue	36
6	Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease 2009 ·Journal of Gastroenterology ·Hyohun Park, Akihito Ishigami, Toshihide Shima, Masayuki Mizuno, Naoki Maruyama, Kanji Yamaguchi, Hironori Mitsuyoshi, Masahito Minami, Kohichiroh Yasui, Yoshito Itoh, Toshikazu Yoshikawa, Michiaki Fukui, Goji Hasegawa, Naoto Nakamura, Mitsuhiro Ohta, Hiroshi Obayashi, Takeshi Okanoue	38
7	The α-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes 2008 ·Clinica Chimica Acta ·Goji Hasegawa, Shizuo Kajiyama, Toru Tanaka, Saeko Imai, (unknown), Aya Fujinami, Mitsuhiro Ohta, Hiroshi Obayashi, Hyohun Park, Koji Nakano, Muhei Tanaka, (unknown), Michiaki Fukui, Toshikazu Yoshikawa, Naoto Nakamura	19
8	Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension 2006 ·Clinica Chimica Acta ·Hyohun Park, Goji Hasegawa, Hiroshi Obayashi, Aya Fujinami, Mitsuhiro Ohta, Hirokazu Hara, Tetsuo Adachi, (unknown), Yoshiki Nakajima, Fumiaki Kimura, Masakazu Ogata, Michiaki Fukui, Toshikazu Yoshikawa, Naoto Nakamura	19
9	Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI 2005 ·Journal of Medical Ultrasonics ·Toshihide Shima, Masayuki Mizuno, (unknown), (unknown), (unknown), Hyohun Park, (unknown), Takeshi Okanoue	2
10	Serum Extracellular Superoxide Dismutase in Patients With Type 2 Diabetes 2003 ·Diabetes Care ·Fumiaki Kimura, Goji Hasegawa, Hiroshi Obayashi, Tetsuo Adachi, (unknown), Mitsuhiro Ohta, Michiaki Fukui, Yoshihiro Kitagawa, Hyohun Park, Naoto Nakamura, Koji Nakano, Toshikazu Yoshikawa	64
11	Serum total bile acid level as a sensitive indicator of hepatic histological improvement in chronic hepatitis C patients responding to interferon treatment 2000 ·Journal of Gastroenterology and Hepatology ·Toshihide Shima, Hisashi Tada, Michio Morimoto, Yoshihiro Nakagawa, (unknown), Toshiyuki Sasaki, Hyohun Park, (unknown), Toshiaki Nakashima, Takeshi Okanoue, Kei Kashima	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact